| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.02. | INIFY LABORATORIES AB: Gastrointestinal Service Launch and Progress in the UK Expansion | 1 | Cision News | ||
| 25.02. | INIFY Laboratories AB: Inify Laboratories: Solid topline growth, strong UK development, and positive response to gastrointestinal diagnostics | 3 | Oslo Børs | ||
| 30.01. | INIFY LABORATORIES AB: Correction: Inify Laboratories - mandatory notification of trade | 1 | Cision News | ||
| INIFY LABORATORIES Aktie jetzt für 0€ handeln | |||||
| 27.01. | INIFY Laboratories AB: Inify Laboratories - mandatory notification of trade | - | Oslo Børs | ||
| 27.01. | INIFY Laboratories AB: Inify Laboratories - Final Results of the Repair Issue | - | Oslo Børs | ||
| 12.01. | INIFY LABORATORIES AB: Inify Laboratories - Commencement of subscription period for Repair Issue | 1 | Cision News | ||
| 19.12.25 | INIFY Laboratories AB: Inify Laboratories announces final results of fully guaranteed private placement | 1 | Oslo Børs | ||
| 19.12.25 | INIFY Laboratories AB: Inify Laboratories - mandatory notification of trade | 1 | Oslo Børs | ||
| 17.12.25 | INIFY Laboratories AB: Inify Laboratories: Key information regarding Repair Issue | 1 | Oslo Børs | ||
| 17.12.25 | INIFY LABORATORIES AB: Inify Laboratories announces preliminary results of fully guaranteed private placement | 1 | Cision News | ||
| 16.12.25 | INIFY Laboratories AB: Inify Laboratories - notification of trade | 2 | Oslo Børs | ||
| 16.12.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 16.12.2025 | 543 | Xetra Newsboard | Das Instrument 48Z0 US4432012072 HOWMET AEROSPACE 3,75 PFD EQUITY wird cum Kapitalmassnahme gehandelt am 16.12.2025 und ex Kapitalmassnahme am 17.12.2025 The instrument 48Z0 US4432012072 HOWMET AEROSPACE... ► Artikel lesen | |
| 09.12.25 | INIFY LABORATORIES AB: Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue | 1 | Cision News | ||
| 04.12.25 | Bulletin from the extraordinary general meeting of Inify Laboratories AB | 1 | Cision News | ||
| 03.12.25 | INIFY LABORATORIES AB: Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue | 1 | Cision News | ||
| 28.11.25 | INIFY Laboratories AB: Financial calendar | 2 | Oslo Børs | ||
| 12.11.25 | INIFY Laboratories AB: Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025 | 1 | Oslo Børs | ||
| 12.11.25 | INIFY Laboratories AB: Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million | - | Oslo Børs | ||
| 29.10.25 | INIFY Laboratories AB: Correction - Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 | 2 | Oslo Børs | ||
| 29.10.25 | INIFY LABORATORIES AB: Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 | 2 | Cision News |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADAPTHEALTH | 10,595 | 0,00 % | Leerink cuts AdaptHealth stock price target on 2025 earnings decline | ||
| FRESENIUS MEDICAL CARE | 40,100 | +0,83 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für FMC von 38 auf 37 Euro gesenkt und die Einstufung auf "Sell" belassen. Die Gewinnentwicklung des Dialysekonzerns sei zunehmend... ► Artikel lesen | |
| FRESENIUS | 46,960 | +0,75 % | Aktuelle Aktien-Empfehlungen: Ströer, Fresenius, Volkswagen & Co. | Mehrere europäische Aktien stehen aktuell im Fokus der Analystenhäuser. Eine Reihe neuer Studien bestätigt Kaufempfehlungen für Unternehmen aus unterschiedlichen Branchen - von Außenwerbung über Industrieanlagen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,300 | -1,87 % | Siemens Healthineers: Drei Belastungen | Am 7. Mai wird Siemens Healthineers Zahlen zum zweiten Quartal publizieren. Die Analysten der DZ Bank glauben, dass diese schwach ausfallen werden. Drei Aspekte belasten derzeit die Daten: Die US-Zölle... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 38,350 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FIREFLY NEUROSCIENCE | 2,740 | 0,00 % | Firefly Neuroscience, Inc.: Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD | Over 22 million Americans are diagnosed with ADHD - yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive1 Firefly's AI-powered EEG/ERP... ► Artikel lesen | |
| ESSILORLUXOTTICA | 204,50 | -0,63 % | EssilorLuxottica And Dolce&Gabbana Renew Global Eyewear Partnership Until 2050 | PARIS (dpa-AFX) - EssilorLuxottica and Dolce&Gabbana announced the extension of their current license agreement through 2050. Under this renewed partnership, EssilorLuxottica will continue to... ► Artikel lesen | |
| GERRESHEIMER | 18,370 | -0,54 % | Aktien Frankfurt Ausblick: Dax-Stabilisierung nimmt Fahrt auf | FRANKFURT (dpa-AFX) - Bei wieder gesunkenen Ölpreisen holt der Dax am Dienstag etwas Schwung auf seiner Erholung vom Tief seit Mai 2025. Der X-Dax signalisierte für den deutschen Leitindex rund eine... ► Artikel lesen | |
| PROGYNY | 17,510 | 0,00 % | Progyny, Inc. - 8-K, Current Report | ||
| CARL ZEISS MEDITEC | 23,540 | -0,25 % | Shortseller-Positionen aktuell: Carl Zeiss Meditec, Gerresheimer, GFT, Lanxess, Renk, Puma, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 2,850 | 0,00 % | Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket | ||
| PROCEPT BIOROBOTICS | 27,140 | 0,00 % | PROCEPT BioRobotics Announces International Launch of the HYDROS Robotic System, Expanding Global Access to AI-Enabled Aquablation Therapy | UK marks first international launch of the HYDROS Robotic System, with additional international expansion planned in 2026SAN JOSE, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq:... ► Artikel lesen | |
| BILLIONTOONE | 69,07 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 17,000 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| HIMS & HERS HEALTH | 21,500 | +0,09 % | Aktien Europa: Hohe Energiepreise schicken Börsen erneut auf Talfahrt | PARIS/LONDON/ZÜRICH (dpa-AFX) - Das Kriegsgeschehen im Nahen Osten hat den europäischen Börsen einen sehr schwachen Wochenauftakt beschert. Der Eurozone-Leitindex EuroStoxx 50 fiel auf den tiefsten... ► Artikel lesen |